Biokraft International AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 112.8 million compared to SEK 97.83 million a year ago. Revenue was SEK 130.09 million compared to SEK 98.35 million a year ago.

Net loss was SEK 58.64 million compared to SEK 10.14 million a year ago. Basic loss per share from continuing operations was SEK 1.35 compared to SEK 0.39 a year ago.